Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
ZIOPHARM, Intrexon Enter into Agreement with NCI 11
Intrexon Enters into Co-Development Agreement with Ziopharm Oncology 12
Ziopharm Expands Co-Development Agreement with Intrexon 13
Mesoblast Enters Into Co-Development Agreement With Intrexon And Ziopharm Oncology 14
Ziopharm Oncology Plans To Enter Into Co-Marketing Agreement For Palifosfamide 16
Licensing Agreements 17
Predictive Therapeutics Enters into Licensing Agreement with ZIOPHARM Oncology 17
Intrexon, Ziopharm Oncology Enter into Licensing Agreement with University of Texas MD Anderson Cancer Center 18
Equity Offering 20
ZIOPHARM Oncology Prices Private Placement of Shares for USD50 Million 20
Ziopharm Oncology Completes Exercise of Over-Allotment Option of Public Offering of Shares for USD100.6 Million 21
Ziopharm Oncology Completes Public Offering Of Shares For US$50 Million 22
ZIOPHARM Oncology Completes Public Offering Of Common Stock For US$50 Million 23
ZIOPHARM Oncology Inc – Key Competitors 25
ZIOPHARM Oncology Inc – Key Employees 26
ZIOPHARM Oncology Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Aug 08, 2018: Ziopharm Oncology reports second quarter 2018 financial results and provides corporate update 28
May 10, 2018: Ziopharm Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update 32
Mar 01, 2018: Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update 34
Nov 06, 2017: ZIOPHARM Oncology Reports Third Quarter 2017 Financial Results and Provides Update on Recent Activities 36
Jul 31, 2017: ZIOPHARM Oncology Reports Second Quarter 2017 Financial Results and Provides Update on Recent Activities 39
May 01, 2017: Ziopharm Oncology Reports First Quarter 2017 Financial Results and Provides Update on Recent Activities 42
Feb 16, 2017: ZIOPHARM Reports Fourth-Quarter 2016 Financial Results and Provides Update on Recent Activities 45
Corporate Communications 47
Aug 07, 2018: Ziopharm Oncology announces changes to its board of directors 47
Sep 28, 2017: ZIOPHARM Oncology Appoints David Mauney, M.D., as Executive Vice President and Chief Business Officer 48
Product News 49
Oct 23, 2017: A Virus, a Gene and a Pill Used to Harness the Immune System to Fight Brain Tumor in Children 49
09/01/2017: ZIOPHARM Oncology to Participate at Upcoming CAR-TCR Summit 50
Clinical Trials 51
Jun 18, 2018: Ziopharm Oncology Reports on Status of Investigational New Drug Application for Phase 1 Trial to Evaluate CD19-targeted CAR T Therapy 51
May 02, 2017: ZIOPHARM Oncology Announces FDA Acceptance of IND for CD33-Specific CAR-T Cell Therapy Targeting Relapsed/Refractory Acute Myeloid Leukemia 52
Jan 31, 2017: ZIOPHARM Utilizing Non-Viral Sleeping Beauty Platform to Rapidly Produce CAR-Expressing T cells Advancing “Point-of-Care” Approach 53
Other Significant Developments 54
Feb 06, 2018: Ziopharm Oncology Addresses Rumors and Stock Volatility, Affirms 2018 Guidance 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ZIOPHARM Oncology Inc, Deals By Therapy Area, 2012 to YTD 2018 9
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ZIOPHARM, Intrexon Enter into Agreement with NCI 11
Intrexon Enters into Co-Development Agreement with Ziopharm Oncology 12
Ziopharm Expands Co-Development Agreement with Intrexon 13
Mesoblast Enters Into Co-Development Agreement With Intrexon And Ziopharm Oncology 14
Ziopharm Oncology Plans To Enter Into Co-Marketing Agreement For Palifosfamide 16
Predictive Therapeutics Enters into Licensing Agreement with ZIOPHARM Oncology 17
Intrexon, Ziopharm Oncology Enter into Licensing Agreement with University of Texas MD Anderson Cancer Center 18
ZIOPHARM Oncology Prices Private Placement of Shares for USD50 Million 20
Ziopharm Oncology Completes Exercise of Over-Allotment Option of Public Offering of Shares for USD100.6 Million 21
Ziopharm Oncology Completes Public Offering Of Shares For US$50 Million 22
ZIOPHARM Oncology Completes Public Offering Of Common Stock For US$50 Million 23
ZIOPHARM Oncology Inc, Key Competitors 25
ZIOPHARM Oncology Inc, Key Employees 26
ZIOPHARM Oncology Inc, Subsidiaries 27
List of Figures
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ZIOPHARM Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9